FDA accepting grant applications for new drugs to treat minor speciesNovember 27, 2018The U.S. Food and Drug Administration (FDA) is accepting applications for grants to support the development of new animal drugs intended to treat uncommon diseases in major or minor species (MUMS).
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
